Target Price Playground

MRNA
$223.37
Gamma & Research: Call Wall: $230 (+3.0%) Put Wall: $220 (-1.5%) True IV %ile: 30.5% Flow: BEARISH (40% Bull)
๐ŸŸข
MRNA IV: 71.2% โ€” LOW (-38.8% vs 30d avg of 116.4%)
Options are cheap vs 30d avg โ€” good time to BUY options (long calls/puts, debit spreads).

๐Ÿ“‹ Strategy

Moderately bullish. Debit, capped max profit + loss.

๐ŸŽฏ Target

1-Click Institutional Target Anchors:
60d from today

โš™๏ธ Legs

LONG CALL ยท $225 ยท Jan '27
Qty 1 ยท Premium $27.78 ยท ฮ” 0.56
SHORT CALL ยท $240 ยท Jan '27
Qty 1 ยท Premium $24.62 ยท ฮ” 0.49
P&L at Expiry Now $223 Target $250 $156 $223 $290
Stock (100 sh) Bull Call Spread Now Target
๐Ÿ’ก Stock vs Options at Target

If MRNA hits $250 by Jan 15: the bull call spread returns +$1,184 (375.0%) on $316 risked, vs +$2,680 (12.0%) for 100 shares on $22,337. Options give 31.2ร— capital efficiency.

๐Ÿ“… Expiry & Gamma Wall Alignment

Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if MRNA is at $250.
Tip: For Covered Calls, selling strikes at or above the $230 Call Wall captures dealer overhead resistance; for Cash-Secured Puts, selling at or below the $220 Put Wall aligns with dealer support.

๐Ÿ“Š Projected Return

P&L if MRNA hits $250 by Jan 15
+$1,184
+375.0% on $316 risked
Max Profit
+$1,184
If the stock โ‰ฅ $240 at expiry
Max Loss
โˆ’$316
Net debit
Break-even
$228.16
+2.14% from spot
Prob. of Profit at Expiry (PoP)
42.1%
Above breakeven ($228.16) ยท Touch Target: 70%
Net ฮ” / ฮ˜ / V
6.83 / 1.36 / -1.87
per spread, per $1 move / day / vol pt
๐Ÿ’พ Log in to save ๐Ÿ“Š My Saved Strategies

๐Ÿ“Š P&L Scenarios โ€” what happens at different prices and dates

MRNA Price Today Dec 6 Dec 26 Jan 15 (exp)
$179 (-20%) -$262 -$253 -$274 -$316
$190 (-15%) -$210 -$195 -$216 -$316
$201 (-10%) -$147 -$122 -$130 -$316
$212 (-5%) -$77 -$36 -$17 -$316
$219 (-2%) -$31 +$20 +$62 -$316
$223 (0%) โ† spot +$0 +$60 +$117 -$316
$228 (+2%) +$32 +$100 +$175 -$32
$235 (+5%) +$81 +$161 +$264 +$638
$246 (+10%) +$165 +$266 +$413 +$1,184
$250 (+12%) โ† target +$198 +$307 +$471 +$1,184
$257 (+15%) +$248 +$369 +$556 +$1,184
$268 (+20%) +$331 +$468 +$684 +$1,184
Uses MRNA's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.